Status:
UNKNOWN
MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer
Lead Sponsor:
Assiut University
Conditions:
Cancer, Rectum
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of our study is to evaluate the accuracy of MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer .
Detailed Description
The current standard of care for patients with T3 or T4 and/or node-positive rectal adenocarcinoma is to offer preoperative concomitant chemoradiotherapy(CRT) followed by total mesorectal excision (TM...
Eligibility Criteria
Inclusion
- Patients \>18 years old with locally advanced rectal adenocarcinoma (T3c-T4 N any, CRM+ M0) treated with neoadjuvant chemoradiotherapy
- Baseline and post treatment MRI scans required for each patient;
- Clinical assessment including digital rectal examination, and endoscopy are needed for each patient
Exclusion
- \- Patient who is not fit for preoperative CRT
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04790227
Start Date
January 1 2022
End Date
July 1 2022
Last Update
February 1 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University
Asyut, Egypt
2
Assuit University
Asyut, Egypt